Abstract:At some time during the clinical course of any patient with metastatic malignant disease, one frequently sees the symptom complex of anorexia, asthenia, loss of body tissues, and inability to conserve normal regulatory functions. This common host response bears no positive correlation to the amount, type, or site of neoplastic tissue, and patients may have obvious widespread tumors without such manifestations. When this systemic response occurs, however, it is readily recognized by the clinician experienced in this area that uncontrolled tumor growth is occurring and that unless such cancerous growth can be inhibited, progressive inanition and ultimate death will occur. All studies described in this paper have been conducted on patients suffering from uncontrolled cancer and its sequelae, as described above. Some of my subjects had not as yet reached the stage of inanition at the time of the experimental work. Most, however, dernonstrated a subnormal nutritional status, and the latter factor must be taken into account in 'an interpretation of the results. Tracer studies with the major energy substrates have been undertaken with the hope of defining the changes that occur in the above clinical syndrome. Because anorexia is invariably present in these subjects, the stoichiornetric regulation and metabolic adaptions that are normally seen with restricted protein and caloric intake have been the subject of consideration. Semistarvation normally results in diminished ATP requirement, because the formation of glycogen, fatty acids, and triglycerides that results from transient excesses of foodstuffs is diminished. This, in turn, causes a decrease in oxygen consumption. Although a transient increase in gluconeogenesis may be seen, the long-term adjustment is that of increased mobilization of fatty acids from adipose tissue, with diminished glucose production from amino acids.' Conservation of the latter ingredient primarily for key enzyme synthesis is necessary for survival (e.g., those enzymes related to fatty acid oxidation). A considerable amount of less recent studies have suggested that the normal decrease in oxidative metabolism does not occur in patients with cancer.2*8 Calculations of energy expenditure, determinations of basal oxygen consumption and COz production, all seem inappropriately high for the condition of study. An example of the latter finding is shown in TABLE 1, in which the basal COz production in a group of control subjects is compared to that of patients with malignant disease. Viewing the data as such, the mean difference between the two groups is only 10% and of little significance. Yet, all subjects in the neoplastic group, though roughly matched in weight to the control group, had lost body weight and had lower caloric intakes at the time these studies were performed. When examined in this context, that is, the nutritional status of the patients, the data become more meaningful, Trace amounts of glucose have been administered to control subjects and patients with metastatic malignant disease in the postabsorptive state (FIGURE 1).

Efficacy of panthenol- and bisabolol-containing lip care as monotherapy for mild-to-moderate cheilitis

Evaluation of effect of a vitamin-based barrier cream on the clinical severity of actinic cheilitis: A preliminary study

A case-control study of the risk of breast cancer in relation to oral contraceptive use.

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients

Lip Mesotherapy with Dexpanthenol as a Novel Approach to Prevent Isotretinoin-Associated Cheilitis

HOW TUMORS AFFECT HOST METABOLISM *

Treatments of actinic cheilitis: A systematic review of the literature

Comparative Study Between Tacrolimus 0.1% Ointment Versus Topical White Soft Petrolatum Jelly in the Treatment of Oral Retinoid-Induced Cheilitis

Ingenol mebutate treatment for actinic cheilitis: clinical, histopathological and p53 profile of 14 cases

Efficacy of photodynamic therapy in actinic cheilitis: A systematic review

Combination of CO2 laser therapy and pulsed dye laser therapy for the treatment of actinic cheilitis

Comparison of Safety and Efficacy Between Calcipotriol Plus Betamethasone Dipropionate Gel and Calcipotriol Scalp Solution As Long-Term Treatment for Scalp Psoriasis in Chinese Patients: a National, Multicentre, Prospective, Randomized, Active-Controlled Phase 4 Trial

Use of lip photoprotection in patients suffering from actinic cheilitis

Fludroxycortide cream as an alternative therapy for actinic cheilitis

A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne

Clinical and biochemical assessment of the effect of topical use of coenzyme Q10 versus topical corticosteroid in management of symptomatic oral lichen planus: randomized controlled clinical trial

Efficacy and safety of a cream containing panthenol, prebiotics, and probiotic lysate for improving sensitive skin symptoms

Chronic nonspecific cheilitis associated with tislelizumab treatment in a patient with a history of tongue squamous cell carcinoma: a case report

Analysis of clinical presentations, lip transepidermal water loss and associated dermatological conditions in patients with chronic cheilitis

A Clinical Study of the Efficacy of Topical Corticosteroids on Dry Eye

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.